农药
Search documents
利民股份:截至11月10日股东总户数为60999户
Zheng Quan Ri Bao· 2025-11-17 11:09
Core Viewpoint - The company, Limin Co., stated on November 17 that as of November 10, 2025, the total number of shareholders is 60,999 [2] Summary by Relevant Sections - Shareholder Information - The total number of shareholders for Limin Co. is reported to be 60,999 as of November 10, 2025 [2]
中农联合:11月17日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-11-17 10:09
截至发稿,中农联合市值为27亿元。 每经头条(nbdtoutiao)——展望"十五五" | 专访尹艳林:让有钱且愿消费的人顺利消费;个税起征点可 提高,最高边际税率可下调,让有关群体少缴税、多收入 2025年1至6月份,中农联合的营业收入构成为:农药行业占比97.8%,化工行业占比2.13%,其他占比 0.07%。 每经AI快讯,中农联合(SZ 003042,收盘价:18.6元)11月17日晚间发布公告称,公司第四届第十七 次董事会临时会议于2025年11月17日在公司会议室以现场结合通讯方式召开。会议审议了《关于公司董 事会换届选举第五届董事会独立董事的议案》等文件。 (记者 曾健辉) ...
中旗股份:实际控制人吴耀军解除质押1150万股
Mei Ri Jing Ji Xin Wen· 2025-11-17 08:01
Group 1 - The core point of the news is that Zhongqi Co., Ltd. announced the release of 11.5 million shares from pledge by its controlling shareholder, Wu Yaojun, who currently has a total of 36.5 million shares pledged, accounting for 26.85% of his holdings [1] - As of the announcement date, Zhongqi Co., Ltd. has a market capitalization of 3.2 billion yuan [2] - For the first half of 2025, the revenue composition of Zhongqi Co., Ltd. is 98.95% from the pesticide industry and 1.05% from other businesses [1]
扬农化工跌2.00%,成交额1.81亿元,主力资金净流出761.55万元
Xin Lang Cai Jing· 2025-11-17 06:24
11月17日,扬农化工盘中下跌2.00%,截至14:01,报67.97元/股,成交1.81亿元,换手率0.65%,总市值 275.55亿元。 资金流向方面,主力资金净流出761.55万元,特大单买入354.97万元,占比1.96%,卖出1091.46万元, 占比6.03%;大单买入4340.45万元,占比23.97%,卖出4365.51万元,占比24.11%。 扬农化工今年以来股价涨19.35%,近5个交易日涨1.03%,近20日跌0.64%,近60日涨5.05%。 资料显示,江苏扬农化工股份有限公司位于江苏省扬州市邗江区开发西路203号扬农大厦,成立日期 1999年12月10日,上市日期2002年4月25日,公司主营业务涉及农药产品的研发、生产和销售。主营业 务收入构成为:原药58.64%,贸易20.65%,制剂18.78%,其他1.93%。 扬农化工所属申万行业为:基础化工-农化制品-农药。所属概念板块包括:中化集团、草甘膦、生态农 业、股权转让、生物农药等。 截至9月30日,扬农化工股东户数1.69万,较上期减少6.49%;人均流通股23883股,较上期增加7.24%。 2025年1月-9月,扬农化工实 ...
11月17日早间重要公告一览
Xi Niu Cai Jing· 2025-11-17 05:40
Group 1 - Company Shikong Technology plans to reduce its holdings by no more than 0.29% of its shares, equivalent to 29,070 shares, starting from December 8, 2025 [1] - Company Rongbai Technology has been designated as the first supplier of sodium-ion battery cathode materials for CATL, with a commitment to purchase at least 60% of its total procurement volume annually [1] - Company Xinnong plans to reduce its holdings by no more than 300,000 shares, representing 0.19% of its total shares, within three months from 15 trading days after the announcement [1][2] Group 2 - Company Zhenai Meijia's controlling shareholder has signed an agreement for share transfer, with no asset restructuring plans for the next 12 months [1] - Company Guochuang High-tech plans to reduce its holdings by no more than 1% of its shares, equivalent to 9,163,300 shares, starting from December 9, 2025 [1] - Company Jiuyang clarifies that it does not engage in food and beverage businesses, focusing solely on small household appliances [6][7] Group 3 - Company Furui's subsidiary has reported a net loss of approximately 30.32 million yuan in the first three quarters, with no expansion plans due to uncertainties in the lithium battery industry [8] - Company Annada has elected Li Chongjun as the chairman of its board [10] - Company Maihe's chairman is under investigation and has been placed under detention [12] Group 4 - Company Luoping Zinc Electric's subsidiary has resumed production at its Jinpo lead-zinc mine after obtaining new mining licenses [13] - Company Hengxing Technology has obtained mining rights for its Longtoushan gold mine [14] - Company Qianli Technology plans to reduce its holdings by no more than 2% of its shares, equivalent to 90,422,000 shares, starting from December 8, 2025 [15] Group 5 - Company Fudan Microelectronics' largest shareholder will change to Guosheng Investment after a share transfer agreement [16] - Company Zhongsheng Pharmaceutical is advancing several clinical trials for innovative drug projects, which carry uncertainties regarding approval and market competition [18] - Company Gaoling Information's shareholders plan to collectively reduce their holdings by no more than 1.49% of the shares [20] Group 6 - Company Chuangye Huikang is in the process of planning a change of control, with uncertainties regarding the implementation of related agreements [21] - Company GAC Group has appointed He Xianqing as the new general manager, succeeding Feng Xingya [22] - Company Heshun Petroleum plans to acquire at least 34% of Kuixin Technology and control 51% of its voting rights [23][24] Group 7 - Company Yifeng Pharmacy's executives plan to reduce their holdings by a total of no more than 213,900 shares due to personal financial needs [26][27]
润丰股份11月14日获融资买入169.72万元,融资余额1.86亿元
Xin Lang Cai Jing· 2025-11-17 01:29
Core Viewpoint - Runfeng Co., Ltd. has shown a mixed performance in terms of stock trading and financial results, with significant growth in revenue and net profit, but a decline in stock price and net buying in margin trading [1][2]. Group 1: Stock Performance - On November 14, Runfeng Co., Ltd. experienced a stock price decline of 1.24%, with a trading volume of 55.46 million yuan [1]. - The margin trading data indicates a net margin buy of -0.93 million yuan on the same day, with a total margin balance of 1.87 billion yuan [1]. - The current margin balance of 1.86 billion yuan represents 0.92% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high level [1]. Group 2: Financial Performance - For the period from January to September 2025, Runfeng Co., Ltd. achieved a revenue of 10.91 billion yuan, reflecting a year-on-year growth of 11.51% [2]. - The net profit attributable to the parent company for the same period was 890 million yuan, showing a substantial year-on-year increase of 160.49% [2]. Group 3: Shareholder and Dividend Information - Since its A-share listing, Runfeng Co., Ltd. has distributed a total of 1.37 billion yuan in dividends, with 992 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 2.90% to 6,630, while the average circulating shares per person increased by 2.99% to 42,284 shares [2][3]. - Among the top ten circulating shareholders, several institutions have adjusted their holdings, with notable decreases in shares held by some funds [3].
新农股份:董事兼副总经理王湛钦计划减持公司股份不超过30万股
Mei Ri Jing Ji Xin Wen· 2025-11-16 07:39
Group 1 - New Agricultural Co., Ltd. announced that its director and deputy general manager, Wang Zhanqin, plans to reduce his shareholding by up to 300,000 shares within three months after 15 trading days from the announcement date, which represents approximately 1.6515% of the company's total share capital [1] - As of January to June 2025, the revenue composition of New Agricultural Co., Ltd. indicates that the pesticide industry accounts for 93.18% of total revenue, while other businesses contribute 6.82% [1] Group 2 - The market capitalization of New Agricultural Co., Ltd. is currently valued at 3.3 billion yuan [2]
江山股份涨2.11%,成交额9307.93万元,主力资金净流出14.70万元
Xin Lang Cai Jing· 2025-11-14 05:52
Core Viewpoint - Jiangshan Co., Ltd. has shown a significant increase in stock price this year, with a 70.50% rise, despite a slight decline in recent trading days [1][2]. Financial Performance - For the period from January to September 2025, Jiangshan Co., Ltd. achieved a revenue of 4.516 billion yuan, representing a year-on-year growth of 5.20% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, marking a substantial increase of 147.91% year-on-year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.05% to 19,100, while the average circulating shares per person increased by 9.95% to 22,509 shares [2]. - The company has distributed a total of 2.693 billion yuan in dividends since its A-share listing, with 384 million yuan distributed over the past three years [3]. Stock Market Activity - On November 14, Jiangshan Co., Ltd. saw its stock price rise by 2.11%, reaching 23.70 yuan per share, with a trading volume of approximately 93.08 million yuan [1]. - The company’s market capitalization stands at 10.206 billion yuan, with a turnover rate of 0.93% [1]. Business Overview - Jiangshan Co., Ltd. primarily engages in the research, production, and sales of agricultural chemicals, including herbicides and insecticides, as well as chemical products and new materials [1]. - The revenue composition of the company includes 61.85% from agricultural products, 14.05% from chemical products, 13.95% from new materials, and 9.40% from thermal power products [1]. Institutional Holdings - As of September 30, 2025, major shareholders include China Europe Fund and Hong Kong Central Clearing Limited, with notable changes in their holdings [3].
蓝丰生化股价涨5.41%,国泰基金旗下1只基金重仓,持有8400股浮盈赚取4200元
Xin Lang Cai Jing· 2025-11-14 05:50
Core Viewpoint - Bluefeng Biochemical experienced a 5.41% increase in stock price, reaching 9.74 CNY per share, with a trading volume of 423 million CNY and a turnover rate of 17.31%, resulting in a total market capitalization of 3.463 billion CNY [1] Group 1: Company Overview - Jiangsu Bluefeng Biochemical Co., Ltd. is located at No. 2 Ningxia Road, Xinyi Economic Development Zone, Jiangsu, and was established on October 11, 1990, with its listing date on December 3, 2010 [1] - The company's main business includes the production and sales of pesticide active ingredients and formulations, as well as fine chemical intermediates and pharmaceutical manufacturing [1] - The revenue composition of the main business is as follows: battery cells 43.84%, modules 31.70%, pesticide active ingredients and formulations 17.20%, sulfuric acid 4.09%, other photovoltaic businesses 1.85%, and other agricultural chemical products 1.32% [1] Group 2: Fund Holdings - According to data from the top ten holdings of funds, one fund under Guotai Fund has a significant position in Bluefeng Biochemical [2] - Guotai Juzi Quantitative Stock Selection Mixed Fund A (023386) held 8,400 shares in the third quarter, accounting for 0.87% of the fund's net value, making it the largest holding [2] - The fund manager, Wu Kefan, has been in position for 2 years and 162 days, with a total asset scale of 2.092 billion CNY and a best fund return of 65.91% during his tenure [2]
蓝丰生化跌2.06%,成交额1.46亿元,主力资金净流出1344.57万元
Xin Lang Cai Jing· 2025-11-14 02:36
11月14日,蓝丰生化盘中下跌2.06%,截至10:15,报9.05元/股,成交1.46亿元,换手率6.05%,总市值 32.18亿元。 资金流向方面,主力资金净流出1344.57万元,特大单买入105.20万元,占比0.72%,卖出384.94万元, 占比2.63%;大单买入1658.33万元,占比11.34%,卖出2723.15万元,占比18.62%。 蓝丰生化今年以来股价涨102.01%,近5个交易日涨2.49%,近20日涨7.23%,近60日涨65.75%。 今年以来蓝丰生化已经18次登上龙虎榜,最近一次登上龙虎榜为11月11日,当日龙虎榜净买入612.18万 元;买入总计1.74亿元 ,占总成交额比19.49%;卖出总计1.68亿元 ,占总成交额比18.81%。 资料显示,江苏蓝丰生物化工股份有限公司位于江苏新沂经济开发区宁夏路2号,成立日期1990年10月 11日,上市日期2010年12月3日,公司主营业务涉及杀菌剂原药及剂型、杀虫剂原药及剂型、除草剂原 药及剂型、精细化工中间体的生产和销售,医药制造板块业务。主营业务收入构成为:电池片43.84%, 组件31.70%,农药原药及制剂17.20%, ...